G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.4 SEK 32% Market Closed
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genovis AB
Other Operating Expenses Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Other Operating Expenses
-kr748k
CAGR 3-Years
55%
CAGR 5-Years
42%
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Other Operating Expenses
kr230m
CAGR 3-Years
112%
CAGR 5-Years
85%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Other Operating Expenses
kr218m
CAGR 3-Years
146%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Other Operating Expenses
-kr12m
CAGR 3-Years
24%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Other Operating Expenses
kr14.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Other Operating Expenses
-kr40.5m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Other Operating Expenses?
Other Operating Expenses
-748k SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Other Operating Expenses amounts to -748k SEK.

What is Genovis AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
42%

Over the last year, the Other Operating Expenses growth was 80%. The average annual Other Operating Expenses growth rates for Genovis AB have been 55% over the past three years , 42% over the past five years .

Back to Top